Brater D C
Department of Medicine, Indiana University School of Medicine, Indianapolis.
Semin Nephrol. 1994 Sep;14(5):479-84.
Diuretic resistance in patients with congesting heart failure is for the most part due to pharmacodynamic factors related to increased reabsorption of solute at other parts of the nephron. This mechanism explains the rationale for using combinations of diuretic agents affecting solute reabsorption at different nephron sites in such patients in contrast to a strategy of escalation of loop diuretic doses. Understanding the mechanisms by which diuretic resistance occurs in patients with CHF has allowed design of appropriate dosing regimens of these drugs and rational use of combinations of diuretics.
充血性心力衰竭患者的利尿剂抵抗在很大程度上归因于与肾单位其他部位溶质重吸收增加相关的药效学因素。这一机制解释了在这类患者中使用影响不同肾单位部位溶质重吸收的利尿剂联合用药的基本原理,这与增加襻利尿剂剂量的策略形成对比。了解慢性心力衰竭患者发生利尿剂抵抗的机制有助于设计这些药物的合适给药方案,并合理使用利尿剂联合用药。